Home » Topics » Conferences

Conferences
RSS

Preclinical results of IL-12 for chronic viral disease

April 30, 1997

Neuraminidase inhibitors highlighted at antiviral conference

April 29, 1997

Target of action of AR-177 elucidated

April 29, 1997

MDL-101731 shows potent antiviral activity in vitro

April 29, 1997

Potent antitumor farnesyltransferase inhibitors discovered by Parke-Davis

April 29, 1997

SKB describes potent, selective IL-8beta receptor antagonists

April 29, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

DuPont Merck describes potent, orally bioavailable cyclic urea HIV protease inhibitor

April 29, 1997

PD-170262: potent and selective PDGF TK inhibitor from Parke-Davis

April 29, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...